These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25241927)

  • 1. Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists.
    Horan JC; Sanyal S; Choi Y; Hill-Drzewi M; Patnaude L; Anderson S; Fogal S; Mao C; Cook BN; Gueneva-Boucheva K; Fisher MB; Hickey E; Pack E; Bannen LC; Chan DS; Mac MB; Ng SM; Wang Y; Xu W; Modis LK; Lemieux RM
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4807-11. PubMed ID: 25241927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Structure-Activity Relationship (SAR) of potent and selective oxadiazole-based agonists of sphingosine-1-phosphate receptor (S1P
    Liu T; Jin J; Chen Y; Xi Q; Hu J; Jia W; Chen X; Li Y; Wang X; Yin D
    Bioorg Chem; 2019 Feb; 82():41-57. PubMed ID: 30268973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.
    Li Z; Chen W; Hale JJ; Lynch CL; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Parent SA; Bergstrom J; Card D; Forrest M; Quackenbush EJ; Wickham LA; Vargas H; Evans RM; Rosen H; Mandala S
    J Med Chem; 2005 Oct; 48(20):6169-73. PubMed ID: 16190743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy.
    Quattropani A; Sauer WH; Crosignani S; Dorbais J; Gerber P; Gonzalez J; Marin D; Muzerelle M; Beltran F; Nichols A; Georgi K; Schneider M; Vitte PA; Eligert V; Novo-Perez L; Hantson J; Nock S; Carboni S; de Souza AL; Arrighi JF; Boschert U; Bombrun A
    ChemMedChem; 2015 Apr; 10(4):688-714. PubMed ID: 25735812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel series of potent S1P1 agonists.
    Crosignani S; Bombrun A; Covini D; Maio M; Marin D; Quattropani A; Swinnen D; Simpson D; Sauer W; Françon B; Martin T; Cambet Y; Nichols A; Martinou I; Burgat-Charvillon F; Rivron D; Donini C; Schott O; Eligert V; Novo-Perez L; Vitte PA; Arrighi JF
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1516-9. PubMed ID: 20149651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist.
    Nakamura T; Asano M; Sekiguchi Y; Mizuno Y; Tamaki K; Kimura T; Nara F; Kawase Y; Shimozato T; Doi H; Kagari T; Tomisato W; Inoue R; Nagasaki M; Yuita H; Oguchi-Oshima K; Kaneko R; Watanabe N; Abe Y; Nishi T
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1788-92. PubMed ID: 22264485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.
    Demont EH; Bailey JM; Bit RA; Brown JA; Campbell CA; Deeks N; Dowell SJ; Eldred C; Gaskin P; Gray JR; Haynes A; Hirst DJ; Holmes DS; Kumar U; Morse MA; Osborne GJ; Renaux JF; Seal GA; Smethurst CA; Taylor S; Watson R; Willis R; Witherington J
    J Med Chem; 2016 Feb; 59(3):1003-20. PubMed ID: 26751273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonists.
    Aguilar N; Mir M; Grima PM; López M; Segarra V; Esteban L; Moreno I; Godessart N; Tarrasón G; Domenech T; Vilella D; Armengol C; Córdoba M; Sabaté M; Casals D; Domínguez M
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7672-6. PubMed ID: 23141913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.
    Vachal P; Toth LM; Hale JJ; Yan L; Mills SG; Chrebet GL; Koehane CA; Hajdu R; Milligan JA; Rosenbach MJ; Mandala S
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3684-7. PubMed ID: 16682185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening.
    Schürer SC; Brown SJ; Gonzalez-Cabrera PJ; Schaeffer MT; Chapman J; Jo E; Chase P; Spicer T; Hodder P; Rosen H
    ACS Chem Biol; 2008 Aug; 3(8):486-98. PubMed ID: 18590333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1).
    Guo J; Watterson SH; Spergel SH; Kempson J; Langevine CM; Shen DR; Yarde M; Cvijic ME; Banas D; Liu R; Suchard SJ; Gillooly K; Taylor T; Rex-Rabe S; Shuster DJ; McIntyre KW; Cornelius G; D'Arienzo C; Marino A; Balimane P; Salter-Cid L; McKinnon M; Barrish JC; Carter PH; Pitts WJ; Xie J; Dyckman AJ
    Bioorg Med Chem Lett; 2016 May; 26(10):2470-2474. PubMed ID: 27055941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
    Jin J; Hu J; Zhou W; Wang X; Xiao Q; Xue N; Yin D; Chen X
    Biochem Pharmacol; 2014 Jul; 90(1):50-61. PubMed ID: 24780445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1.
    Evindar G; Deng H; Bernier SG; Doyle E; Lorusso J; Morgan BA; Westlin WF
    Bioorg Med Chem Lett; 2013 Jan; 23(2):472-5. PubMed ID: 23245510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel S1P1 receptor agonists--part 1: From pyrazoles to thiophenes.
    Bolli MH; Müller C; Mathys B; Abele S; Birker M; Bravo R; Bur D; Hess P; Kohl C; Lehmann D; Nayler O; Rey M; Meyer S; Scherz M; Schmidt G; Steiner B; Treiber A; Velker J; Weller T
    J Med Chem; 2013 Dec; 56(23):9737-55. PubMed ID: 24266709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-stage optimization of a tercyclic class of S1P3-sparing, S1P1 receptor agonists.
    Horan JC; Kuzmich D; Liu P; DiSalvo D; Lord J; Mao C; Hopkins TD; Yu H; Harcken C; Betageri R; Hill-Drzewi M; Patenaude L; Patel M; Fletcher K; Terenzzio D; Linehan B; Xia H; Patel M; Studwell D; Miller C; Hickey E; Levin JI; Smith D; Kemper RA; Modis LK; Bannen LC; Chan DS; Mac MB; Ng S; Wang Y; Xu W; Lemieux RM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):466-471. PubMed ID: 26687487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P
    Xiao HY; Watterson SH; Langevine CM; Srivastava AS; Ko SS; Zhang Y; Cherney RJ; Guo WW; Gilmore JL; Sheppeck JE; Wu DR; Li P; Ramasamy D; Arunachalam P; Mathur A; Taylor TL; Shuster DJ; McIntyre KW; Shen DR; Yarde M; Cvijic ME; Marino AM; Balimane PV; Yang Z; Banas DM; Cornelius G; D'Arienzo CJ; Warrack BM; Lehman-McKeeman L; Salter-Cid LM; Xie J; Barrish JC; Carter PH; Dyckman AJ; Dhar TG
    J Med Chem; 2016 Nov; 59(21):9837-9854. PubMed ID: 27726358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
    Skidmore J; Heer J; Johnson CN; Norton D; Redshaw S; Sweeting J; Hurst D; Cridland A; Vesey D; Wall I; Ahmed M; Rivers D; Myatt J; Giblin G; Philpott K; Kumar U; Stevens A; Bit RA; Haynes A; Taylor S; Watson R; Witherington J; Demont E; Heightman TD
    J Med Chem; 2014 Dec; 57(24):10424-42. PubMed ID: 25431977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cenerimod, a novel selective S1P
    Piali L; Birker-Robaczewska M; Lescop C; Froidevaux S; Schmitz N; Morrison K; Kohl C; Rey M; Studer R; Vezzali E; Hess P; Clozel M; Steiner B; Bolli MH; Nayler O
    Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperazine oxadiazole inhibitors of acetyl-CoA carboxylase.
    Bourbeau MP; Siegmund A; Allen JG; Shu H; Fotsch C; Bartberger MD; Kim KW; Komorowski R; Graham M; Busby J; Wang M; Meyer J; Xu Y; Salyers K; Fielden M; Véniant MM; Gu W
    J Med Chem; 2013 Dec; 56(24):10132-41. PubMed ID: 24294923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists.
    Meng Q; Zhao B; Xu Q; Xu X; Deng G; Li C; Luan L; Ren F; Wang H; Xu H; Xu Y; Zhang H; Xiang JN; Elliott JD; Guo TB; Zhao Y; Zhang W; Lu H; Lin X
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2794-7. PubMed ID: 22429468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.